PNC Financial Services Group
VIVO

PNC Financial Services Group’s Meridian Bioscience Inc VIVO Stock Holding History

PNC Financial Services Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,750
Closed -$457K – 4902
2022
Q4 		$457K Sell
13,750
-22,187
-62% -$715K ﹤0.01% 1578
2022
Q3 		$1.13M Sell
35,937
-8,779
-20% -$284K ﹤0.01% 1056
2022
Q2 		$1.36M Sell
44,716
-9,428
-17% -$255K ﹤0.01% 1014
2022
Q1 		$1.41M Sell
54,144
-13,692
-20% -$326K ﹤0.01% 1074
2021
Q4 		$1.38M Sell
67,836
-2,014
-3% -$38.6K ﹤0.01% 1114
2021
Q3 		$1.34M Sell
69,850
-2,407
-3% -$48K ﹤0.01% 1056
2021
Q2 		$1.6M Sell
72,257
-848
-1% -$18K ﹤0.01% 1007
2021
Q1 		$1.92M Sell
73,105
-897
-1% -$21.3K ﹤0.01% 896
2020
Q4 		$1.38M Buy
74,002
+32
+0% +$598 ﹤0.01% 989
2020
Q3 		$1.25M Sell
73,970
-1,126
-1% -$21.9K ﹤0.01% 953
2020
Q2 		$1.75M Sell
75,096
-21,505
-22% -$312K ﹤0.01% 823
2020
Q1 		$810K Sell
96,601
-1,520
-2% -$12.8K ﹤0.01% 1058
2019
Q4 		$959K Buy
98,121
+1,508
+2% +$14.2K ﹤0.01% 1111
2019
Q3 		$917K Buy
96,613
+161
+0.2% +$1.7K ﹤0.01% 1301
2019
Q2 		$1.14M Sell
96,452
-1,614
-2% -$19.4K ﹤0.01% 1228
2019
Q1 		$1.73M Sell
98,066
-271
-0.3% -$4.51K ﹤0.01% 1085
2018
Q4 		$1.71M Sell
98,337
-994
-1% -$17K ﹤0.01% 1051
2018
Q3 		$1.48M Sell
99,331
-16,149
-14% -$250K ﹤0.01% 1180
2018
Q2 		$1.84M Sell
115,480
-38
-0% -$567 ﹤0.01% 1081
2018
Q1 		$1.64M Sell
115,518
-1,020
-0.9% -$15.1K ﹤0.01% 1103
2017
Q4 		$1.63M Buy
116,538
+11,655
+11% +$171K ﹤0.01% 1118
2017
Q3 		$1.5M Buy
104,883
+1,001
+1% +$14.3K ﹤0.01% 1123
2017
Q2 		$1.64M Buy
103,882
+485
+0.5% +$6.99K ﹤0.01% 1077
2017
Q1 		$1.43M Buy
103,397
+5,413
+6% +$75.7K ﹤0.01% 1148
2016
Q4 		$1.74M Buy
97,984
+3,814
+4% +$67K ﹤0.01% 1057
2016
Q3 		$1.82M Buy
94,170
+872
+0.9% +$17.1K ﹤0.01% 1031
2016
Q2 		$1.82M Buy
93,298
+449
+0.5% +$8.8K ﹤0.01% 982
2016
Q1 		$1.91M Buy
92,849
+11,149
+14% +$220K ﹤0.01% 959
2015
Q4 		$1.68M Buy
81,700
+7
+0% +$134 ﹤0.01% 986
2015
Q3 		$1.4M Sell
81,693
-185
-0.2% -$3.38K ﹤0.01% 1096
2015
Q2 		$1.53M Buy
81,878
+415
+0.5% +$7.7K ﹤0.01% 1085
2015
Q1 		$1.55M Buy
81,463
+1,118
+1% +$20.7K ﹤0.01% 1071
2014
Q4 		$1.32M Buy
80,345
+370
+0.5% +$6.35K ﹤0.01% 1082
2014
Q3 		$1.41M Buy
79,975
+2,500
+3% +$49.1K ﹤0.01% 1004
2014
Q2 		$1.6M Hold
77,475
– – ﹤0.01% 940
2014
Q1 		$1.69M Buy
77,475
+330
+0.4% +$7.56K ﹤0.01% 903
2013
Q4 		$2.05M Sell
77,145
-6,967
-8% -$171K ﹤0.01% 822
2013
Q3 		$1.99M Buy
84,112
+230
+0.3% +$5.37K ﹤0.01% 808
2013
Q2 		$1.8M Buy
+83,882
New +$1.81M ﹤0.01% 814

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PNC Financial Services Group's VIVO Position: Q1 2023 in Review

PNC Financial Services Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 13,750 shares — an estimated $457K sold.

PNC Financial Services Group first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $2.05M in Q4 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • PNC Financial Services Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 13,750 Meridian Bioscience Inc shares in Q1 2023, an estimated $457K.
  • PNC Financial Services Group first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • PNC Financial Services Group's Meridian Bioscience Inc position peaked at $2.05M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.